SANTA CLARA, Calif.--(BUSINESS WIRE)--OptiMedica® Corporation, a leading developer of ophthalmic therapeutic devices, today introduced a new portfolio of products, including the Pascal Laser Indirect Ophthalmoscope (LIO) which was granted marketing clearance by the FDA this month, Automated LaserLog™ with treatment summary printout and Intelligent Device Management. These products increase treatment options and efficiencies for the ophthalmic practice and will be showcased this week at the 110th annual American Academy of Ophthalmology (AAO) annual meeting in Las Vegas.
